Key Data on Health and Health Care by Race and Ethnicity March 15, 2023 Report This chartpack examines how people of color fare compared to White people across a broad array of measures of health coverage, access, and use; health status, outcomes, and behaviors; and social determinants of health to provide insight into the status of racial disparities in health and health care.
The Estimated Value of Tax Exemption for Nonprofit Hospitals Was About $28 Billion in 2020 March 14, 2023 Issue Brief This data note estimates that the value of tax exemption for nonprofit hospitals was $28 billion in 2020. This amount exceeds estimated charity care costs among nonprofit hospitals in 2020 ($16 billion), though charity care represents only a portion of the community benefits reported by nonprofit hospitals.
Nonprofit Hospitals’ Tax-Exempt Status Worth About $28 Billion, New KFF Analysis Finds March 14, 2023 News Release Editor’s Note: The press release was updated on March 27, 2023, to reflect corrections in the underlying analysis, resulting in a modest increase in the total estimated value of tax exemption, from $27.6 to $28.1 billion. The tax-exempt status of the nation’s nonprofit hospitals collectively was worth about $28 billion…
Challenges to the FDA’s Approval of Medication Abortion Pills Could Curtail Access Throughout the United States March 14, 2023 News Release In anticipation of a ruling in a case with enormous implications for access to medication abortion in the United States, a new KFF brief explains the impact of this case, and others filed in federal courts, involving the FDA’s regulation of medication abortion. The case that has gotten the most…
As Congress Considers Reauthorizing PEPFAR, A New Policy Watch Asks and Answers Fundamental Questions March 13, 2023 News Release As Congress considers reauthorizing the President’s Emergency Plan for AIDS Relief (PEPFAR) for a fourth time, a new KFF Policy Watch details key facts about the program and top issues related to its authorization and funding. Created in 2003 as the U.S. government’s signature global health effort in the fight…
Legal Challenges to the FDA Approval of Medication Abortion Pills March 13, 2023 Issue Brief This issue brief details the Alliance of Hippocratic Medicine challenge to the FDA’s approval of the abortion pill, mifepristone. It provides context for the challenge, as well as what some of the possible rulings in the case could mean for access to medication abortion.
PEPFAR Reauthorization 2023: Key Issues March 13, 2023 Blog This year, Congress will consider reauthorization of the President’s Emergency Plan for AIDS Relief (PEPFAR). This Policy Watch provides fast facts about the program and top issues related to its authorization and funding.
How Much Could COVID-19 Vaccines Cost the U.S. After Commercialization? March 10, 2023 Issue Brief This analysis illustrates the potential total cost of Pfizer and Moderna COVID-19 vaccines, based on their publicly-announced expected prices, once they enter the U.S. commercial market. It compares the average price paid by the federal government for the COVID-19 bivalent boosters to the estimated average commercial prices across different scenarios.
PEPFAR Policy Resource Hub – PEPFAR COP/ROP Guidance March 9, 2023 Issue Brief The COP/ROP guidance underpins the development of annual plans by both bilateral and regional PEPFAR programs.
Unwinding the Continuous Enrollment Provision: Perspectives from Current Medicaid Enrollees March 9, 2023 Issue Brief This brief describes 10 key points about the unwinding of the Medicaid continuous enrollment requirement, highlighting data and analyses that can inform the unwinding process as well as recent legislation and guidance issued by the Centers for Medicare and Medicaid Services (CMS) to help states prepare for the end of the continuous enrollment provision.